|
advertisement
|
|
|
|
| Healthcare IT and Biotechnology News Release |
| News Home :: Healthcare IT and Biotechnology News Releases :: More News Releases on this day |
| Date of Publication: Wednesday, November 21, 2007 |
Research IT Partnership with Nycomed Expands Genedata`s Business Model |
| Swiss-based drug discovery informatics provider Genedata AG today announced the establishment of a novel research IT alliance with Nycomed, a global leader in innovative pharmaceuticals. |
Basel -- Swiss-based drug discovery informatics provider Genedata AG today announced the establishment of a novel research IT alliance with Nycomed, a global leader in innovative pharmaceuticals.
An increasing number of pharmaceutical companies are outsourcing their research IT services to specialized partners in order to increase focus on their core competencies, drive IT innovation and subsequently improve IT performance and reduce overall R&D costs. In line with this trend and Nycomed`s new R&D operating model, Genedata and Nycomed are establishing a strategic partnership that will capitalize on Genedata`s extensive technological expertise to support Nycomed`s proprietary R&D data and knowledge management.
The existing Nycomed research IT infrastructure will be adapted to the new R&D operating model, with Genedata supporting Nycomed in developing and implementing scientific databases and applications for research data management and scientific analysis. The implementation of novel solutions and more efficient workflows is key in this effort. To enhance the smooth integration of Genedata’s expertise into the R&D operations of Nycomed, Genedata has established an office on location, at the Nycomed site in Konstanz, Germany.
“Our new R&D strategy and operating model is aiming for a highly flexible organization that focuses on its core competencies to fill our pipeline with medicines that have true medical utility. For this we were seeking an outsourcing partner able to provide superior technology as well as expertise, and launch quality solutions in a short span of time,“ explained Dr. Karl Zech, Senior Vice President Discovery and Proof of Concept Development at Nycomed. “In addition, effective partnering requires an established, trusting and highly interactive relationship, which makes Genedata a distinguished first choice.”
Dr. Othmar Pfannes, CEO of Genedata AG, said: “We are delighted and committed to take a prolific long-term collaboration to an even higher level, supporting Nycomed to leverage in-house resources and gain competitive advantage. Taking on operational responsibilities represents a new Genedata business approach, that, in complexity and scope, goes beyond the customary provision of software products and services.”
|
|
| Other News Items Published on the Wednesday, November 21, 2007 |
|
|